APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ophthalmic Medicine Industry Growth and Trends Forecast to 2032

Report ID 17401914012 January 202694 pages

Choose your research edition.

Industry ResearchOphthalmic Medicine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Medicine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Ophthalmic Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Medicine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ophthalmic Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Medicine include Zhejiang Shapuaisi Pharmaceutical, Shenyang Xingqi Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Novaliq, Mentholatum, Bausch Health and Alcon NV, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmic Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmic Medicine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmic Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmic Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ophthalmic Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmic Medicine Market by Company

Zhejiang Shapuaisi Pharmaceutical

Shenyang Xingqi Pharmaceutical Co.,Ltd.

Chengdu Kanghong Pharmaceutical Group

Santen Pharmaceutica

Novaliq

Mentholatum

Bausch Health

Alcon NV

Ophthalmic Medicine Segment by Type

Eye Drops

Gelling Agent

Tablet

Eye Ointment

Injection

Ophthalmic Medicine Segment by Application

Cataract

Anti-infective

Anti-fatigue and Dryness

Ophthalmic Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmic Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ophthalmic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Eye Drops Table 2. Major Company of Gelling Agent Table 3. Major Company of Tablet Table 4. Major Company of Eye Ointment Table 5. Major Company of Injection Table 6. Global Ophthalmic Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Ophthalmic Medicine Sales by Type (2021-2026) & (K Units) Table 8. Global Ophthalmic Medicine Sales Market Share in Volume by Type (2021-2026) Table 9. Global Ophthalmic Medicine Sales by Type (2021-2026) & (US$ Million) Table 10. Global Ophthalmic Medicine Sales Market Share in Value by Type (2021-2026) Table 11. Global Ophthalmic Medicine Price by Type (2021-2026) & (US$/Unit) Table 12. Global Ophthalmic Medicine Sales by Type (2027-2032) & (K Units) Table 13. Global Ophthalmic Medicine Sales Market Share in Volume by Type (2027-2032) Table 14. Global Ophthalmic Medicine Sales by Type (2027-2032) & (US$ Million) Table 15. Global Ophthalmic Medicine Sales Market Share in Value by Type (2027-2032) Table 16. Global Ophthalmic Medicine Price by Type (2027-2032) & (US$/Unit) Table 17. North America Ophthalmic Medicine Sales by Type (2021-2026) & (K Units) Table 18. North America Ophthalmic Medicine Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Ophthalmic Medicine Sales by Type (2021-2026) & (K Units) Table 20. Europe Ophthalmic Medicine Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Ophthalmic Medicine Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Ophthalmic Medicine Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Ophthalmic Medicine Sales by Type (2021-2026) & (K Units) Table 24. Latin America Ophthalmic Medicine Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Ophthalmic Medicine Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Ophthalmic Medicine Sales by Type (2021-2026) & (US$ Million) Table 27. Ophthalmic Medicine Industry Trends Table 28. Ophthalmic Medicine Industry Drivers Table 29. Ophthalmic Medicine Industry Opportunities and Challenges Table 30. Ophthalmic Medicine Industry Restraints Table 31. Global Ophthalmic Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Ophthalmic Medicine Revenue Market Share by Company (2021-2026) Table 33. Global Ophthalmic Medicine Sales by Company (2021-2026) & (K Units) Table 34. Global Ophthalmic Medicine Sales Share by Company (2021-2026) Table 35. Global Ophthalmic Medicine Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Ophthalmic Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Ophthalmic Medicine Major Company Production Sites and Headquarters Table 38. Global Ophthalmic Medicine Company, Product Type & Application Table 39. Global Ophthalmic Medicine Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Ophthalmic Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Ophthalmic Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Ophthalmic Medicine Sales by Region (2021-2026) & (K Units) Table 44. Global Ophthalmic Medicine Sales Market Share in Volume by Region (2021-2026) Table 45. Global Ophthalmic Medicine Sales by Region (2021-2026) & (US$ Million) Table 46. Global Ophthalmic Medicine Sales Market Share in Value by Region (2021-2026) Table 47. Global Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Ophthalmic Medicine Sales by Region (2027-2032) & (K Units) Table 49. Global Ophthalmic Medicine Sales Market Share in Volume by Region (2027-2032) Table 50. Global Ophthalmic Medicine Sales by Region (2027-2032) & (US$ Million) Table 51. Global Ophthalmic Medicine Sales Market Share in Value by Region (2027-2032) Table 52. Global Ophthalmic Medicine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Ophthalmic Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Ophthalmic Medicine Sales by Application (2021-2026) & (K Units) Table 55. Global Ophthalmic Medicine Sales Market Share in Volume by Application (2021-2026) Table 56. Global Ophthalmic Medicine Sales by Application (2021-2026) & (US$ Million) Table 57. Global Ophthalmic Medicine Sales Market Share in Value by Application (2021-2026) Table 58. Global Ophthalmic Medicine Price by Application (2021-2026) & (US$/Unit) Table 59. Global Ophthalmic Medicine Sales by Application (2027-2032) & (K Units) Table 60. Global Ophthalmic Medicine Sales Market Share in Volume by Application (2027-2032) Table 61. Global Ophthalmic Medicine Sales by Application (2027-2032) & (US$ Million) Table 62. Global Ophthalmic Medicine Sales Market Share in Value by Application (2027-2032) Table 63. Global Ophthalmic Medicine Price by Application (2027-2032) & (US$/Unit) Table 64. North America Ophthalmic Medicine Sales by Application (2021-2026) & (K Units) Table 65. North America Ophthalmic Medicine Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Ophthalmic Medicine Sales by Application (2021-2026) & (K Units) Table 67. Europe Ophthalmic Medicine Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Ophthalmic Medicine Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Ophthalmic Medicine Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Ophthalmic Medicine Sales by Application (2021-2026) & (K Units) Table 71. Latin America Ophthalmic Medicine Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Ophthalmic Medicine Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Ophthalmic Medicine Sales by Application (2021-2026) & (US$ Million) Table 74. Zhejiang Shapuaisi Pharmaceutical Company Information Table 75. Zhejiang Shapuaisi Pharmaceutical Business Overview Table 76. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio Table 78. Zhejiang Shapuaisi Pharmaceutical Recent Development Table 79. Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information Table 80. Shenyang Xingqi Pharmaceutical Co.,Ltd. Business Overview Table 81. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio Table 83. Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Development Table 84. Chengdu Kanghong Pharmaceutical Group Company Information Table 85. Chengdu Kanghong Pharmaceutical Group Business Overview Table 86. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio Table 88. Chengdu Kanghong Pharmaceutical Group Recent Development Table 89. Santen Pharmaceutica Company Information Table 90. Santen Pharmaceutica Business Overview Table 91. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Santen Pharmaceutica Ophthalmic Medicine Product Portfolio Table 93. Santen Pharmaceutica Recent Development Table 94. Novaliq Company Information Table 95. Novaliq Business Overview Table 96. Novaliq Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Novaliq Ophthalmic Medicine Product Portfolio Table 98. Novaliq Recent Development Table 99. Mentholatum Company Information Table 100. Mentholatum Business Overview Table 101. Mentholatum Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Mentholatum Ophthalmic Medicine Product Portfolio Table 103. Mentholatum Recent Development Table 104. Bausch Health Company Information Table 105. Bausch Health Business Overview Table 106. Bausch Health Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Bausch Health Ophthalmic Medicine Product Portfolio Table 108. Bausch Health Recent Development Table 109. Alcon NV Company Information Table 110. Alcon NV Business Overview Table 111. Alcon NV Ophthalmic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Alcon NV Ophthalmic Medicine Product Portfolio Table 113. Alcon NV Recent Development Table 114. North America Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. North America Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 116. North America Ophthalmic Medicine Sales Market Share by Country (2021-2026) Table 117. North America Ophthalmic Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 118. North America Ophthalmic Medicine Sales Market Share Forecast by Country (2027-2032) Table 119. North America Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Ophthalmic Medicine Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Ophthalmic Medicine Market Share by Country (2021-2026) Table 122. North America Ophthalmic Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Ophthalmic Medicine Market Share Forecast by Country (2027-2032) Table 124. Europe Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Europe Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 126. Europe Ophthalmic Medicine Sales Market Share by Country (2021-2026) Table 127. Europe Ophthalmic Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 128. Europe Ophthalmic Medicine Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Ophthalmic Medicine Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Ophthalmic Medicine Market Share by Country (2021-2026) Table 132. Europe Ophthalmic Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Ophthalmic Medicine Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 136. Asia-Pacific Ophthalmic Medicine Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Ophthalmic Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 138. Asia-Pacific Ophthalmic Medicine Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Ophthalmic Medicine Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Ophthalmic Medicine Market Share by Country (2021-2026) Table 142. Asia-Pacific Ophthalmic Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Ophthalmic Medicine Market Share Forecast by Country (2027-2032) Table 144. Latin America Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Latin America Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 146. Latin America Ophthalmic Medicine Sales Market Share by Country (2021-2026) Table 147. Latin America Ophthalmic Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 148. Latin America Ophthalmic Medicine Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Ophthalmic Medicine Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Ophthalmic Medicine Market Share by Country (2021-2026) Table 152. Latin America Ophthalmic Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Ophthalmic Medicine Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 156. Middle East and Africa Ophthalmic Medicine Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Ophthalmic Medicine Sales Forecast by Country (2027-2032) & (K Units) Table 158. Middle East and Africa Ophthalmic Medicine Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Ophthalmic Medicine Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Ophthalmic Medicine Market Share by Country (2021-2026) Table 162. Middle East and Africa Ophthalmic Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Ophthalmic Medicine Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Ophthalmic Medicine Distributors List Table 167. Ophthalmic Medicine Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Ophthalmic Medicine Image Figure 2. Global Ophthalmic Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Medicine Sales (2021-2032) & (K Units) Figure 5. Eye Drops Image Figure 6. Global Eye Drops Sales YoY Growth (2021-2032) & (K Units) Figure 7. Gelling Agent Image Figure 8. Global Gelling Agent Sales YoY Growth (2021-2032) & (K Units) Figure 9. Tablet Image Figure 10. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. Eye Ointment Image Figure 12. Global Eye Ointment Sales YoY Growth (2021-2032) & (K Units) Figure 13. Injection Image Figure 14. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Ophthalmic Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Ophthalmic Medicine Market Share by Type 2025 VS 2032 Figure 17. North America Ophthalmic Medicine Sales Market Share in Volume by Type in 2025 Figure 18. North America Ophthalmic Medicine Sales Market Share in Value by Type in 2025 Figure 19. Europe Ophthalmic Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Europe Ophthalmic Medicine Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Ophthalmic Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Ophthalmic Medicine Sales Market Share in Value by Type in 2025 Figure 23. Latin America Ophthalmic Medicine Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Ophthalmic Medicine Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Ophthalmic Medicine Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Ophthalmic Medicine Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Ophthalmic Medicine Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Cataract Image Figure 30. Global Cataract Sales YoY Growth (2021-2032) & (K Units) Figure 31. Anti-infective Image Figure 32. Global Anti-infective Sales YoY Growth (2021-2032) & (K Units) Figure 33. Anti-fatigue and Dryness Image Figure 34. Global Anti-fatigue and Dryness Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Ophthalmic Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Ophthalmic Medicine Market Share by Application 2025 VS 2032 Figure 37. North America Ophthalmic Medicine Sales Market Share in Volume by Application in 2025 Figure 38. North America Ophthalmic Medicine Sales Market Share in Value by Application in 2025 Figure 39. Europe Ophthalmic Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Europe Ophthalmic Medicine Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Ophthalmic Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Ophthalmic Medicine Sales Market Share in Value by Application in 2025 Figure 43. Latin America Ophthalmic Medicine Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Ophthalmic Medicine Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Ophthalmic Medicine Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Ophthalmic Medicine Sales Market Share in Value by Application in 2025 Figure 47. North America Ophthalmic Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Ophthalmic Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Ophthalmic Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ophthalmic Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Ophthalmic Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Ophthalmic Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Ophthalmic Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Ophthalmic Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Ophthalmic Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ophthalmic Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Ophthalmic Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Ophthalmic Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Ophthalmic Medicine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Ophthalmic Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Ophthalmic Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Ophthalmic Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Ophthalmic Medicine Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Ophthalmic Medicine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Eye Drops
  • Gelling Agent
  • Tablet
  • Eye Ointment
  • Injection
Applications
  • Cataract
  • Anti-infective
  • Anti-fatigue and Dryness
Companies covered
  • Zhejiang Shapuaisi Pharmaceutical
  • Shenyang Xingqi Pharmaceutical Co.,Ltd.
  • Chengdu Kanghong Pharmaceutical Group
  • Santen Pharmaceutica
  • Novaliq
  • Mentholatum
  • Bausch Health
  • Alcon NV

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ophthalmic Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ophthalmic Medicine Market by Type
  6. 1.3.1 Eye Drops
  7. 1.3.2 Gelling Agent
  8. 1.3.3 Tablet
  9. 1.3.4 Eye Ointment
  10. 1.3.5 Injection
  11. 1.4 Global Ophthalmic Medicine Market Size by Type
  12. 1.4.1 Global Ophthalmic Medicine Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Ophthalmic Medicine Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Ophthalmic Medicine Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Ophthalmic Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Ophthalmic Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Ophthalmic Medicine Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Ophthalmic Medicine Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Ophthalmic Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ophthalmic Medicine Industry Trends
  2. 2.2 Ophthalmic Medicine Industry Drivers
  3. 2.3 Ophthalmic Medicine Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ophthalmic Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Ophthalmic Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Ophthalmic Medicine Price (2021-2026)
  4. 3.4 Global Ophthalmic Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmic Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Ophthalmic Medicine Company, Product Type & Application
  7. 3.7 Global Ophthalmic Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmic Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmic Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmic Medicine Tier 1, Tier 2, and Tier 3
4 Ophthalmic Medicine Regional Status and Outlook
  1. 4.1 Global Ophthalmic Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ophthalmic Medicine Historic Market Size by Region
  3. 4.2.1 Global Ophthalmic Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ophthalmic Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ophthalmic Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ophthalmic Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Ophthalmic Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ophthalmic Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ophthalmic Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ophthalmic Medicine by Application
  1. 5.1 Ophthalmic Medicine Market by Application
  2. 5.1.1 Cataract
  3. 5.1.2 Anti-infective
  4. 5.1.3 Anti-fatigue and Dryness
  5. 5.2 Global Ophthalmic Medicine Market Size by Application
  6. 5.2.1 Global Ophthalmic Medicine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ophthalmic Medicine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ophthalmic Medicine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ophthalmic Medicine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ophthalmic Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ophthalmic Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ophthalmic Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ophthalmic Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Shapuaisi Pharmaceutical
  2. 6.1.1 Zhejiang Shapuaisi Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Shapuaisi Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio
  6. 6.1.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments
  7. 6.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
  8. 6.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
  9. 6.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Business Overview
  10. 6.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio
  12. 6.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments
  13. 6.3 Chengdu Kanghong Pharmaceutical Group
  14. 6.3.1 Chengdu Kanghong Pharmaceutical Group Company Information
  15. 6.3.2 Chengdu Kanghong Pharmaceutical Group Business Overview
  16. 6.3.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio
  18. 6.3.5 Chengdu Kanghong Pharmaceutical Group Recent Developments
  19. 6.4 Santen Pharmaceutica
  20. 6.4.1 Santen Pharmaceutica Company Information
  21. 6.4.2 Santen Pharmaceutica Business Overview
  22. 6.4.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Santen Pharmaceutica Ophthalmic Medicine Product Portfolio
  24. 6.4.5 Santen Pharmaceutica Recent Developments
  25. 6.5 Novaliq
  26. 6.5.1 Novaliq Company Information
  27. 6.5.2 Novaliq Business Overview
  28. 6.5.3 Novaliq Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novaliq Ophthalmic Medicine Product Portfolio
  30. 6.5.5 Novaliq Recent Developments
  31. 6.6 Mentholatum
  32. 6.6.1 Mentholatum Company Information
  33. 6.6.2 Mentholatum Business Overview
  34. 6.6.3 Mentholatum Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mentholatum Ophthalmic Medicine Product Portfolio
  36. 6.6.5 Mentholatum Recent Developments
  37. 6.7 Bausch Health
  38. 6.7.1 Bausch Health Company Information
  39. 6.7.2 Bausch Health Business Overview
  40. 6.7.3 Bausch Health Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bausch Health Ophthalmic Medicine Product Portfolio
  42. 6.7.5 Bausch Health Recent Developments
  43. 6.8 Alcon NV
  44. 6.8.1 Alcon NV Company Information
  45. 6.8.2 Alcon NV Business Overview
  46. 6.8.3 Alcon NV Ophthalmic Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Alcon NV Ophthalmic Medicine Product Portfolio
  48. 6.8.5 Alcon NV Recent Developments
7 North America by Country
  1. 7.1 North America Ophthalmic Medicine Sales by Country
  2. 7.1.1 North America Ophthalmic Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ophthalmic Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Ophthalmic Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ophthalmic Medicine Market Size by Country
  6. 7.2.1 North America Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ophthalmic Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Ophthalmic Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ophthalmic Medicine Sales by Country
  2. 8.1.1 Europe Ophthalmic Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ophthalmic Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Ophthalmic Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ophthalmic Medicine Market Size by Country
  6. 8.2.1 Europe Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ophthalmic Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ophthalmic Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ophthalmic Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Ophthalmic Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ophthalmic Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ophthalmic Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ophthalmic Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ophthalmic Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ophthalmic Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ophthalmic Medicine Sales by Country
  2. 10.1.1 South America Ophthalmic Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ophthalmic Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Ophthalmic Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ophthalmic Medicine Market Size by Country
  6. 10.2.1 South America Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ophthalmic Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Ophthalmic Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ophthalmic Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Ophthalmic Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ophthalmic Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ophthalmic Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ophthalmic Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Ophthalmic Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ophthalmic Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ophthalmic Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ophthalmic Medicine Value Chain Analysis
  2. 12.1.1 Ophthalmic Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ophthalmic Medicine Production Mode & Process
  7. 12.2 Ophthalmic Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ophthalmic Medicine Distributors
  10. 12.2.3 Ophthalmic Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst